StockData
CVS HEALTH Corp logo

CVS HEALTH Corp

CVSNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 19/3027% below fair value
$91.41+2.90 (+3.28%)

Close on Nov 3, 2026Market cap $116.91BP/E 10.7Yield 2.91%

Cvs Health Labcorp Holdings (LH) — Total Revenues by Year

Labcorp Holdings (LH) — Total Revenues ($M)

Cvs Health Labcorp Holdings (LH) — Total Revenues: $13,952M in FY2025, up 7.2% from a year earlier.

Latest, FY2025
13,952
Period ended Dec 31, 2025
Change on a year earlier
+7.2%
13,009 in FY2024
History
10 years
Since FY2016
Sources
1
Labcorp Holdings Inc. SEC 10-K (XBRL)

Where the FY2025 figure comes from

Source: Labcorp Holdings Inc. SEC 10-K (XBRL) ↗

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedLabcorp Holdings (LH) — Total Revenues ($M)Year on yearSource
FY2025Dec 31, 202513,952+7.2%Labcorp Holdings Inc. SEC 10-K (XBRL) ↗
FY2024Dec 31, 202413,009+7.0%Labcorp Holdings Inc. SEC 10-K (XBRL) ↗
FY2023Dec 31, 202312,162+2.5%Labcorp Holdings Inc. SEC 10-K (XBRL) ↗
FY2022Dec 31, 202211,864-9.7%Labcorp Holdings Inc. SEC 10-K (XBRL) ↗
FY2021Dec 31, 202113,136-6.0%Labcorp Holdings Inc. SEC 10-K (XBRL) ↗
FY2020Dec 31, 202013,978+21.0%Labcorp Holdings Inc. SEC 10-K (XBRL) ↗
FY2019Dec 31, 201911,555+2.0%Labcorp Holdings Inc. SEC 10-K (XBRL) ↗
FY2018Dec 31, 201811,333+9.9%Labcorp Holdings Inc. SEC 10-K (XBRL) ↗
FY2017Dec 31, 201710,308+7.9%Labcorp Holdings Inc. SEC 10-K (XBRL) ↗
FY2016Dec 31, 20169,553–Labcorp Holdings Inc. SEC 10-K (XBRL) ↗

Cite this data

StockData. (2026). Cvs Health Labcorp Holdings (LH) — Total Revenues ($M), annual FY2016–FY2025 [Data set]. Compiled from Cvs Health SEC filings and investor materials. https://stockdatahq.com/stocks/cvs/kpis/peer-lh-revenue

See every metric in the Cvs Health KPI table. Data updated Oct 28, 2026.

See a number that looks wrong?